The newest contactless health monitoring technology Anura allows smartphone manufacturers and carriers to integrate digital health solutions into their devices.

NuraLogix, a global pioneer in contactless health monitoring, will showcase a slew of new AnuraTM platform features at MWC 2023. AnuraTM can provide over 30 health parameters using mobile and desktop devices that are already in the hands of billions of people, allowing the mobile industry to integrate digital health solutions into various aspects of the healthcare industry as well as sectors such as retail, automotive, and smart cities.

‍

NuraLogix's groundbreaking technology, launched in 2015, enables third-party clients such as health practitioners, mobile carriers and handset makers, insurance organizations, and wellness programs to assist consumers in better managing their physical and emotional health. NuraLogix will demonstrate its current capacity to do metabolic and blood biomarker health risk assessments for several chronic illnesses, such as measuring HbA1c and fasting glucose, as well as the risk of type 2 diabetes, hypertension, and hypertriglyceridemia, at MWC 2023. Anura may be found in the Ontario/Canada Pavilion at exhibit #6C75.

‍

The 'Healthy Selfie'

‍

AnuraTM is the only video-based contactless health monitoring system that uses mobile and desktop devices to detect vital signs and deliver health risk evaluations. Unlike smartwatches, health trackers, and rings that use light sensors to detect blood flow, AnuraTM can do so with a video selfie.

‍

NuraLogix's unique Transdermal Optical Imaging (TOITM) technology, a revolutionary kind of Remote Photoplethysmography, powers the platform (rPPG). It recognizes a person's face, determines key regions of interest, and harvests blood flow data, which is then coupled with strong AI data models generated from tens of thousands of patients with various health issues.

‍

The findings are shown on an easy-to-read results screen and include data on dozens of health parameters* such as heart rate, breathing rate, and cuffless blood pressure. It assesses the health risks associated with some of the most common chronic illnesses, such as Type 2 Diabetes, Hypertension, Cardiovascular Disease, and Mental Health.

‍

NuraLogix's projected model research has presently featured in 10 worldwide peer-reviewed research papers, with three further publications in the works, using data from over 40,000 patients with different diseases. NuraLogix also possesses 13 original US patents. Its most recent models have been shown to accurately predict if a subject's HbA1c is more than 5.7% or Fasting Blood Glucose is greater than 5.5mmol/L.

‍

Moreover, NuraLogix claimed in January 2023 that it now has the capacity to monitor blood pressure with an accuracy equivalent to a standard deviation of error of less than 8mmHg, often regarded as the "Holy Grail" of contactless blood pressure measurement. 

‍

"The wireless sector has already played an essential part in remote and new health solutions, and with 5G adoption rising, its capacity to power the health industry is accelerating," said Dr Keith Thompson, Chief Medical Officer of NuraLogix. "Platforms like Anura enable handset manufacturers and carriers to create or collaborate with additional third parties to deploy digital health solutions that can make a meaningful difference in society; our agnostic hardware and operating system approach paves the way to a world where health vitals are constantly monitored with just a glance at a smartphone, bathroom mirror, TV screen, or kiosk."

Flexible Modular Delivery

Anura includes capabilities for investigational use and go-to-market solutions to enable its customers (companies like NTT Data, Bupa Group, AIA, and FWD) to create flexible, custom programs to meet the needs of their clients by combining different Anura capabilities, such as: Physiological Health Vitals/Indexes that measure Blood Pressure, Cardiac Workload, Pulse/Heart Rate, Breathing/Respiratory Rate, Irregular Heart Rate Mental stress, anxiety, and depression health risks are assessed through mental health/risk assessments. Assessments of Physiological Health and Risk that look at the risks of T2 Diabetes, HbA1c, Cardiovascular Disease, Fasting Blood Glucose, Hypertension Risk, Hypercholesterolemia Risk, Hypertriglyceridemia (10-year forecast of risk of mortality from Heart Attack or Stroke),

‍